Bipolar I Disorder
Links shared publicly online about this topic
Bipolar I Disorder... | Facebook
facebook.com — “National bipolar foundation wrote: bipolar i disorder is a recurrent... join facebook to connect with national bipolar foundation and others you may know.” View full resource at facebook.com
Most Recently Shared on January 30, 2010 at 10:51 pm By:
Bipolar Foundation Health Organization
Bipolar I Disorder is a recurrent disorder - more than 90% of individuals who have a single Manic Episode go on... http://bit.ly/awvXVa
Saphris approved for schizophrenia and bipolar I disorder - MPR
empr.com — “The FDA has approved Saphris (asenapine sublingual tablets, from Schering-Plough), a psychotropic agent, for the acute treatment of schizophrenia in adults and the acute treatment of manic or mixed episodes associated with bipolar I disorder with or without psychotic features in adults.” View full resource at empr.com
Most Recently Shared on August 14, 2009 at 3:41 pm By:
MPR News: Saphris approved for schizophrenia and bipolar I disorder: The FDA has approved Saphris (asen.. http://bit.ly/A4RkP
Asenapine for schizophrenia and bipolar I disorder — Current Psychiatry Online
currentpsychiatry.com — “Asenapine for schizophrenia and bipolar I disorder — Current Psychiatry Online” View full resource at currentpsychiatry.com
Most Recently Shared on December 18, 2009 at 3:17 pm By:
Current Psychiatry Psychiatry and Medical Journal
Asenapine (Saphris)--new med for schizophrenia & bipolar I--offers unique receptor profile, sublingual delivery http://bit.ly/5BO6G2
Board Review of Bipolar I Disorder | COMLEX USMLE Board Review Blogger
comlexflashcards.com — “I. Bipolar I Disorder- mood disorder in which” View full resource at comlexflashcards.com
Most Recently Shared on July 21, 2010 at 5:10 pm By:
Peter H Brown Doctor and Psychologist
Board Review of Bipolar I Disorder | COMLEX USMLE Board Review Blogger http://bit.ly/aM8XrP #bipolar
Geodon approved for adjunctive maintenance treatment of bipolar I disorder - MPR
empr.com — “The FDA has approved Geodon (ziprasidone HCl, from Pfizer) capsules for the maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults.” View full resource at empr.com
Most Recently Shared on November 20, 2009 at 10:14 pm By:
MPR News: Geodon approved for adjunctive maintenance treatment of bipolar I disorder: The FDA has approved Geodon (... http://bit.ly/7IlmwH
Phase 3 Study of Cariprazine for Acute Mania in Bipolar I Disorder - MPR
empr.com — “Forest Laboratories and Geodon Richter PIc announced results from its Phase 3 study of cariprazine (RGH-188) for the treatment of patients with acute mania associated with bipolar I disorder.” View full resource at empr.com
Most Recently Shared on October 5, 2011 at 2:20 pm By:
Phase 3 Study of Cariprazine for Acute Mania in #BipolarDisorder http://ow.ly/6O8ut
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
drugs.com — “Abilify (aripiprazole) is used to treat schizophrenia, Bipolar I Disorder, depression and irritability associated with autistic disorder. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 21, 2011 at 10:15 pm By:
Drugs and Devices OW OW Health
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Li... http://bit.ly/fuFJIk #drug
MedWire News - Psychiatry - ‘Mixicity should be extended beyond bipolar I disorder’
medwire-news.md — “MedWire News Bipolar I disorder patients with a lifetime history of exclusively mixed, but not manic, episodes are at increased risk for suicide and have higher comorbidity rates than other patients with the condition, study results show. MedWire News” View full resource at medwire-news.md
Most Recently Shared on August 12, 2011 at 12:01 pm By:
Timothy Lomauro Doctor, Psychologist, and PhD
‘Mixicity should be extended beyond #bipolar I disorder’ - http://bit.ly/re9Lmn #psych
MedWire News - Psychiatry - Long-term functioning impairments common in bipolar I disorder
medwire-news.md — “MedWire News Many patients with bipolar I disorder continue to experience functioning impairments 15 years after first being hospitalized for a manic episode, US research shows. MedWire News” View full resource at medwire-news.md
Most Recently Shared on April 13, 2011 at 11:04 am By:
Long-term functioning impairments common in bipolar I disorder http://bit.ly/h3FYvE #bipolardisorder
MedWire News - Psychiatry - Temperaments linked to clinical features and course in bipolar I disorder
medwire-news.md — “MedWire News Research suggests that cyclothymic and hyperthymic temperaments are associated with differences in clinical features in patients with bipolar I disorder, such as number of hospitalizations, disease course, family history, and comorbid disorders. MedWire News” View full resource at medwire-news.md
Most Recently Shared on February 7, 2012 at 4:53 pm By:
Temperaments linked to clinical features and course in bipolar I disorder http://t.co/N8J3XOg8 #psychiatry
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium | Pharmainfo.net
pharmainfo.net — “ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium | Pharmainfo.net” View full resource at pharmainfo.net
Most Recently Shared on February 25, 2011 at 1:15 am By:
Peter H Brown Doctor and Psychologist
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of ... http://bit.ly/hQ3HCe #bipolar
MedWire News - Psychiatry - Family study provides support for pediatric bipolar I disorder validity
medwire-news.md — “MedWire News Researchers have found an increased risk for bipolar I disorder in the relatives of children with the condition. MedWire News” View full resource at medwire-news.md
Most Recently Shared on June 22, 2010 at 7:07 pm By:
Peter H Brown Doctor and Psychologist
MedWire News - Psychiatry - Family study provides support for ... http://bit.ly/9qa8jc #bipolar
RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed The Time To Relapse In Patients With Bipolar I Disorder
medicalnewstoday.com — “New data demonstrate that maintenance therapy with RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Treatment (RLAT) significantly delayed the time to relapse compared to placebo in patients with” View full resource at medicalnewstoday.com
Most Recently Shared on May 20, 2009 at 12:16 pm By:
psychiatryrounds Psychiatry and Support
RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed The Time To Relapse In Patients With Bipolar .. http://tinyurl.com/qv6vj7
Executive Functioning in Twins with Bipolar I Disorder and Healthy Co-Twins -- Juselius et al. 24 (6): 599 -- Archives of Clinical Neuropsychology
acn.oxfordjournals.org — “Executive Functioning in Twins with Bipolar I Disorder and Healthy Co-Twins -- Juselius et al. 24 (6): 599 -- Archives of Clinical Neuropsychology” View full resource at acn.oxfordjournals.org
Most Recently Shared on October 3, 2009 at 2:17 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Bipolar disorder linked to impairment in executive brain function (semantic fluency) http://ow.ly/swpo
MSD Receives European Approval Of Its Atypical Antipsychotic Medication SYCREST(R) For The Treatment Of Manic Episodes In Bipolar I Disorder | Psydir News
news.psydir.com — “MSD (MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A). announced today that the European Commission has approved the Marketing Authorization Application (MAA) for SYCREST (asenapine) sublingual tablets for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults...” View full resource at news.psydir.com
Most Recently Shared on September 5, 2010 at 11:05 am By:
MSD Receives European Approval Of Its Atypical Antipsychotic Medication SYCREST(R) For The… http://goo.gl/fb/GbooI
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Bipolar Foundation
On April 16, 2007, concerned people met to form the National Bipolar Foundation, the first national group of its kind dedicated to eradicating the disease,
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Current Psychiatry
Current Psychiatry is a peer-reviewed psychiatry journal
Advertisement
